Pregled bibliografske jedinice broj: 1275960
Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease
Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease // BMC Cardiovascular Disorders, 23 (2023), 268, 8 doi:10.1186/s12872-023-03310-y (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1275960 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of galectin-3 in diagnosis and severity
assessment of epicardial artery lesions
in patients with suspected coronary artery
disease
Autori
Bošnjak, Ivica ; Bedeković, Dražen ; Selthofer- Relatić, Kristina ; Roguljić, Hrvoje ; Mihaljević, Ivica ; Bilić-Ćurčić, Ines
Izvornik
BMC Cardiovascular Disorders (1471-2261) 23
(2023);
268, 8
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Biomarker ; Chronic coronary syndrome ; Coronary artery disease ; Galectin-3
Sažetak
Background: This study aimed to investigate the possible role of serum galectin-3 (Gal-3) levels in the diagnosis and assessment of significant epicardial artery lesions in patients with suspected coronary artery disease (CAD). Methods: This was a single-center cross sectional cohort study including 168 subjects with suspected CAD and indications for coronary angiography divided into three groups: percutaneous coronary intervention (PCI) group (N 64), coronary artery bypass graft surgery (CABG) group (N 57), and group with no coronary stenosis (N 47). Gal-3 levels were measured and the syntax score (Ss) was calculated. Results: The mean value of Gal-3 in the PCI and CABG group was 19.98 ng/ml, while in the control group, it was 9.51 ng/ml (p < 0.001). The highest value of Gal-3 was found in the group of subjects with three-vessel disease (p < 0.001). When subgroups were analyzed by Gal-3 levels (< 17.8 ng/ml low, 18.8-25.9 ng/ml intermediate, > 25 ng/ml high risk) there was a significant difference between at least two Gal-3 groups for the arithmetic mean of Syntax score (p < 0.001). The syntax I's arithmetic mean at low and intermediate-risk Gal-3 levels was significantly lower than at high-risk Gal-3 levels (p < 0.001). Conclusion: Gal-3 could be used as an additional tool for diagnosis and severity assessment of atherosclerotic disease in patients with suspected CAD. Furthermore, it could help identify high-risk subjects in patients with stable CAD.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Ines Bilić-Ćurčić
(autor)
Kristina Selthofer-Relatić
(autor)
Hrvoje Roguljić
(autor)
Ivica Mihaljević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE